Nivolumab in NSCLC: latest evidence and clinical potential

Therapeutic Advances in Medical Oncology
Raghav SundarRoss A Soo

Abstract

New insight on the interaction between the immune system and tumor has identified the programmed death-1/programmed death-1 ligand pathway to be a key player in evading host immune response. The immune checkpoint modulator, nivolumab (BMS-936558/ONO-4538), is the first PD-1 inhibitor to gain regulatory approval, for the treatment of patients with unresectable melanoma. This review will discuss results from early phase studies of nivolumab in solid tumors including non-small cell lung cancer (NSCLC) as well as studies of nivolumab in combination with chemotherapy, other immune modulators and molecular targeted therapy in patients with NSCLC.

References

Feb 1, 1995·American Journal of Clinical Oncology·J H SchillerM L Levitt
Jan 1, 1997·International Journal of Clinical & Laboratory Research·B J Van den Eynde, T Boon
Apr 3, 2001·The Journal of Experimental Medicine·S Y TsengH Tsuchiya
Aug 7, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jun KonishiMasaharu Nishimura
Oct 16, 2004·Immunity·Ching-Tai HuangDario A A Vignali
Sep 17, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Eiji SuzukiSteven M Albelda
Aug 22, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Trina J Stewart, Scott I Abrams
Oct 9, 2007·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·C GrandeJ Casal
Nov 6, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Stephanie G DowneySteven A Rosenberg
Jan 5, 2008·Annual Review of Immunology·Mary E KeirArlene H Sharpe
Sep 6, 2008·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Lei ZhangSidong Xiong
Nov 26, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jedd D WolchokF Stephen Hodi
Dec 17, 2009·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Benjamin SolomonD Ross Camidge
Feb 18, 2010·Proceedings of the National Academy of Sciences of the United States of America·Michael A CurranJames P Allison
Jun 3, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Julie R BrahmerSuzanne L Topalian
Aug 13, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Krithika N KodumudiJulie Y Djeu
Jul 12, 2011·Physiological Reviews·Shom GoelRakesh K Jain
Mar 23, 2012·Nature Reviews. Cancer·Drew M Pardoll
May 2, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Thomas J LynchMartin Reck
May 23, 2012·Clinical & Developmental Immunology·Esdy N RozaliW Joost Lesterhuis
Jun 5, 2012·The New England Journal of Medicine·Suzanne L TopalianMario Sznol
Jun 5, 2012·The New England Journal of Medicine·Julie R BrahmerJon M Wigginton
Aug 8, 2012·Clinical Lung Cancer·Jennifer M BolandMarie Christine Aubry
Aug 29, 2012·Journal of the National Cancer Institute·Geoffrey R OxnardLawrence H Schwartz
Oct 17, 2012·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Leow Pay ChinSai-Hong I Ou
Oct 23, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Daniel S ChenF Stephen Hodi
Nov 20, 2012·Annual Review of Immunology·Guido KroemerLaurence Zitvogel
Jan 8, 2013·Journal of the National Cancer Institute·Silvia C Formenti, Sandra Demaria
Feb 13, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Julie R Brahmer
Feb 27, 2013·Cancer Research·Yuhui HuangRakesh K Jain
Jun 4, 2013·The New England Journal of Medicine·Omid HamidAntoni Ribas
Jun 4, 2013·The New England Journal of Medicine·Jedd D WolchokMario Sznol
Jun 19, 2013·The Oncologist·Leslie A FecherJeffrey S Weber
Aug 3, 2013·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Caroline RobertAlexander M M Eggermont
Aug 3, 2013·Neoplasia : an International Journal for Oncology Research·Javier FreireLuis M Montuenga
Sep 21, 2013·Cancer Immunology, Immunotherapy : CII·Benjamin FreyUdo S Gaipl
Oct 1, 2013·Chinese Medical Sciences Journal = Chung-kuo I Hsüeh K'o Hsüeh Tsa Chih·Yan-yan ChenJie-ming Qu
Oct 29, 2013·Oncotarget·John WrangleStephen B Baylin

❮ Previous
Next ❯

Citations

Dec 19, 2015·Expert Review of Clinical Pharmacology·Emanuela RossiCesare Gridelli
Nov 17, 2015·Expert Review of Anticancer Therapy·Carlo GenovaFrancesco Grossi
Jul 28, 2015·Expert Opinion on Biological Therapy·Erika RijavecFrancesco Grossi
Feb 11, 2016·Immunotherapy·Bing Xia, Roy S Herbst
Mar 1, 2016·Future Oncology·Ana Collazo-Lorduy, Matthew D Galsky
Aug 25, 2015·Biochimica Et Biophysica Acta·Hassan Lemjabbar-AlaouiPetra Buchanan
Sep 18, 2015·Journal of Medical Case Reports·Alberto Lopez-PastoriniErich Stoelben
Apr 22, 2016·Respirology : Official Journal of the Asian Pacific Society of Respirology·Antonius StevenBruce W Robinson
Jun 6, 2016·Current Treatment Options in Oncology·Sylvia C EiseleEudocia Q Lee
Oct 5, 2016·JCI Insight·Grit S Herter-SprieKwok-Kin Wong
Jul 28, 2016·Clinical Lung Cancer·Priyanka KhannaLuis Corrales-Rodriguez
Jun 22, 2016·Nature Reviews. Urology·Maria I CarloRobert J Motzer
Nov 8, 2015·The Lancet Oncology·Hideho OkadaDavid A Reardon
Jul 20, 2016·Expert Opinion on Biological Therapy·Yi Lin, Hideho Okada
Sep 7, 2016·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Ming-Chung Jiang
Oct 30, 2016·Annals of Oncology : Official Journal of the European Society for Medical Oncology·K A Olaussen, S Postel-Vinay
Feb 18, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Barbara MeloskyVera Hirsh
Mar 30, 2017·Expert Opinion on Drug Safety·Carlo GenovaFrancesco Grossi
Sep 16, 2015·Cancers·Vishal BoolellVinod Ganju
Dec 27, 2017·International Journal of Cancer. Journal International Du Cancer·Lu DaiZhiqiang Qin
Oct 11, 2017·British Journal of Cancer·Julius Malte VahlSusetta Finotto
Jan 16, 2018·Indian Journal of Medical and Paediatric Oncology : Official Journal of Indian Society of Medical & Paediatric Oncology·Pratishtha B Chaudhari
Jan 10, 2018·Frontiers in Immunology·Isabel Corraliza-GorjónLeonor Kremer
Sep 13, 2016·British Journal of Nursing : BJN·Rachel Thomas
Jun 18, 2017·Cancer Biotherapy & Radiopharmaceuticals·Fang GengBangwei Cao
Jan 14, 2018·Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete·S Troyanova-SlavkovaL Kowalzick
Jun 17, 2016·Journal of Thoracic Imaging·Anastasios DimouJohn Wrangle
Jan 24, 2018·The Cancer Journal·Theodore S NowickiAntoni Ribas
Jul 13, 2016·The Oncologist·Jeffrey S WeberDirk Schadendorf
Feb 22, 2018·Turkish Journal of Emergency Medicine·Funda Karbek AkarcaYusuf Ali Altunci
Sep 15, 2017·Oncotarget·Huiqin Guo, Kangla Tsung
Sep 15, 2017·Oncotarget·Lu DaiZhiqiang Qin

❮ Previous
Next ❯

Clinical Trials Mentioned

NCT01721759
NCT02175017
NCT01642004
NCT01673867
NCT02041533
NCT02066636
NCT01454102
NCT01714739
NCT01968109
NCT01629758

Related Concepts

Related Feeds

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.